Lung, D702GC0000, Artemide-Lung04

ClinicalTrials.gov ID NCT06868277

A Phase III, Randomized, Double-blind, Multicenter, Global Study of Rilvegostomig or Pembrolizumab Monotherapy for the First-line Treatment of Patients With PD-L1-high Metastatic Non-small Cell Lung Cancer.

Lung, D763QC00001, Tropion-Lung17

ClinicalTrials.gov ID: NCT07291037

A Phase III, Randomised, Open-Label, Multicentre Study of Datopotamab Deruxtecan or Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer Without Actionable Genomic Alterations 

Breast, JZP598-208

ClinicalTrials.gov ID: NCT07102381

The purpose of this study is to see if zanidatamab is safe and effective, when combined with chemotherapy, in treating people who has Human Epidermal Growth Factor Receptor 2 (HER2)-positive, early-stage breast cancer.

 

Breast, A012303, Shortstop-HER2

ClinicalTrials.gov ID: NCT06876714

Cancer Q&A with HOA: Making Healthy Choices

Cancer Q&A with HOA: Keeping Hope Alive Amidst a Cancer Diagnosis

Patient Newsletter 2025 December

New Patient Guide

Sound Bath

Patient Newsletter 2025 November

Pages